Cell Resource Center Provides Access to the World’s Most Comprehensive Source for Cell Biology Research Tools

CARLSBAD, Calif.–Invitrogen, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the launch of the life-science industry’s first comprehensive online resource for cell biology information and technology. The Invitrogen Cell Resource Center is a Web portal that brings together educational resources and the latest technologies for advancing cellular research. This Web-based hub enables scientists to access the broadest range of products and scientific resources for cell biology from a single source.

The new portal was designed through customer input from more than 700 life scientists from around the world. It provides information highlighting the breadth of what can be accomplished in the laboratory with any given cell type, with information organized across technologies that support the cellular workflow. Researchers can also access information about various cell types through links to useful technical information, third-party video protocols, published research, assays, and reagents, as well as systems and devices for building workflows for their experiments.

The Cell Resource Center features a broad range of highly characterized primary cells, stem cells including embryonic stem cells, induced pluripotent stem cells, and reprogramming technologies, along with more than 200 validated assays for basic research, drug discovery and screening. As part of the rollout of this industry resource, Invitrogen is also launching a new comprehensive line of GIBCO® rat neural cell products including neural stem cells, neurons and glial cells, marking the first cells within its industry-leading portfolio of neurobiology products.

These cells have been validated with media and reagents that include Neurobasal™ Medium, B27 supplement and StemPro® NSC SFM. Also available for the first time are cell engineering tools to allow targeted, stable integration of genetic material into the genome of pluripotent stem cells and primary cells for screening and discovery analysis.

Cynthia Klein, Sr. Lab Manager, Stem Cell & Reproductive Biology, OB/GYN School of Medicine, Stanford University

“The Invitrogen Cell Resource Center is a helpful guide to finding most everything you need in one place regarding many types of cell culture systems. It provides information about cells, in addition to the media, what type of research the cells are used for and what you need to grow them successfully.”

Nicolas Barthelemy, President, Life Technologies’ Cell Systems Division

“The Invitrogen Cell Resource Center provides the life-science community with the most comprehensive source of essential information and enabling technologies for cellular research. The creation of this unique portal, with input from more than 700 pilot customers around the world, demonstrates Invitrogen’s promise of being there for our customers to support their needs everyday through differentiated technologies and truly innovative ways of connecting with the scientific community.”

Additional Resources:

Technology Chalkboard

What’s New?

About Invitrogen Products

Life Technologies’ Invitrogen brand represents the life-science industry’s most comprehensive portfolio of platform-independent, essential technologies for disease and drug research, bioproduction and diagnostics. Invitrogen products provide the broadest range of differentiated reagents, kits and bench-top devices for the dynamic research and application needs of scientists around the world. Through its Invitrogen and Applied Biosystems brand of optimized instrument systems and workflows, Life Technologies markets the most comprehensive portfolio of solutions for molecular and cell biology. Invitrogen and Applied Biosystems products are used in nearly every major laboratory in the world. For more information, please visit: https://www.invitrogen.com/everyday and www.appliedbiosystems.com.

About Life Technologies

Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com.

Safe Harbor Statement

This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

For research use only. Not intended for any animal or human therapeutic or diagnostic use, unless otherwise indicated.

Copyright 2009. Life Technologies Corporation. All rights reserved. Invitrogen is a trademark of Life Technologies in the US and/or certain other countries. Neurobasal is a trademark of Invitrogen and Life Technologies. GIBCO and StemPro are registered trademarks of Invitrogen and Life Technologies.